Health2Go eye clinics to lift care
An innovative new approach to eye care will roll out at Flinders to reduce waiting times and deliver appropriate and timely care for patients with a […]
New glaucoma test set to roll out
A $304,000 State Government seed grant will be used to commercialise a pioneering solution for assessing glaucoma risk in clinical settings. South Australian company Seonix Bio […]
Glaucoma linked to increased risk of dementia
Medical researchers have found a link between a type of glaucoma and an increased risk of developing dementia, according to a new study published in the […]
Top award for world-leading glaucoma research
Flinders is at the forefront of finding solutions for glaucoma, the leading cause of irreversible blindness worldwide. By 2020, glaucoma will affect 80 million people worldwide, […]
Visionary research to help save sight
The eyesight of millions may be saved thanks to Flinders University’s visionary genetic research which has been awarded more than $9 million in federal funding. A […]
New focus on correcting refractive vision
While doctors take delight in solving the common issue of refractive vision error by prescribing eye glasses, Flinders University researchers have found that many patients are […]
Gene discovery sheds light on childhood glaucoma
Ophthalmology experts at Flinders have played a pivotal role in discovering a new genetic cause for primary congenital glaucoma – a leading cause of blindness in children.
Genetic links helpful for glaucoma treatment
The discovery of new genetic areas linked to an increased risk of glaucoma will help prevent one of the leading cause of irreversible blindness in Asia.
The fight against dementia, cancer and eye-disease receives $5.1m funding
Dementia, bowel cancer and glaucoma are among diseases to be addressed by researchers at Flinders with National Health and Medical Research Council funding of nearly $5.1 million.